Abstract
The promise of gene therapy to treat diseases remains largely unfulfilled. Past setbacks and the complexity of the delivery systems used, in terms of both targeting the appropriate cells and inducing expression of products at therapeutic levels, thus far have prevented significant success for gene therapy. Smooth muscle disorders represent a unique target for gene therapy. In many cases, smooth muscle is readily accessible and, to induce a therapeutic effect, will not require very high levels of gene product expression. This allows a lower efficiency of gene transfer to be successful. With these important features in mind, we believe that naked DNA transfer of potassium ion channels represents a novel and successful way to treat smooth muscle disorders. Herein, we present a rationale for treating erectile dysfunction, a smooth muscle disorder of the cavernosal bodies of the penis, with naked DNA gene transfer therapy. By inserting the hSlo gene, which codes for Maxipotassium channels, into smooth muscle cells, we can improve smooth muscle relaxation in the corporal bodies and thus improve erectile function. This method of gene transfer has proven to be safe and effective for erectile dysfunction, and human trials are ongoing.
References
Feb 1, 1989·The Journal of Urology·N IshiiM Shirai
Oct 23, 1982·Lancet·R Virag
Apr 1, 1995·The American Journal of Physiology·M T Nelson, J M Quayle
Jan 1, 1993·The American Journal of Physiology·A P MorenoD C Spray
Jan 1, 1996·Drugs & Aging·A P LeaJ A Balfour
Apr 1, 1997·Biology of Reproduction·H GarbánN F González-Cadavid
May 15, 1998·The New England Journal of Medicine·I GoldsteinP A Wicker
Nov 7, 1998·British Journal of Urology
Mar 31, 1999·International Journal of Impotence Research·P Kunelius, O Lukkarinen
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·H C ChampionP J Kadowitz
Oct 24, 2001·Biology of Reproduction·T J BivalacquaW J Hellstrom
Sep 12, 2002·Biology of Reproduction·Thomas R MageeNestor F Gonzalez-Cadavid
Feb 28, 2003·International Journal of Impotence Research·R S RogersT F Lue
Apr 18, 2003·BJU International·M B ChancellorN Yoshimura
Jun 11, 2003·The Journal of Urology·A MelmanG J Christ
Jul 25, 2003·Drugs of Today·C G Stief
Jan 22, 2004·Current Urology Reports·George J Christ
Sep 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·George J ChristArnold Melman
Dec 22, 2004·Lancet·H Bobby GasparAdrian J Thrasher
Mar 10, 2005·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Howard D Pomeranz, Abdhish R Bhavsar
Mar 11, 2005·Advanced Drug Delivery Reviews·Alain Rolland
Mar 30, 2005·BJU International·Zhou-Jun ShenZhao-Dian Chen
Jun 21, 2005·European Urology·Arnold MelmanGeorge Christ
Citations
Feb 9, 2007·International Journal of Impotence Research·K P DaviesA Melman
Nov 7, 2007·The Urologic Clinics of North America·Arnold Melman
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·William O BrantTom F Lue
Jul 30, 2014·Critical Reviews in Toxicology·Andrew D MonnotBrent L Finley